Palomino Laboratories Inc. financial data

Location
New York, NY
Fiscal year end
31 December
Latest financial report
10-Q - Q3 2025 - 14 Nov 2025

Key Ratios

Label TTM Value / Value Unit Change %
Current Ratio 21% %
Debt-to-equity 63% %
Return On Equity -166% % -116%
Return On Assets -503% % -355%

Shares

Label TTM Value / Value Unit Change %
Entity Common Stock, Shares Outstanding 18,770,686 shares 275%
Common Stock, Shares, Outstanding 17,611,292 shares 252%
Entity Public Float $0 USD
Common Stock, Value, Issued $1,761 USD 252%
Weighted Average Number of Shares Outstanding, Basic 3,383,919 shares 104%
Weighted Average Number of Shares Outstanding, Diluted 3,383,919 shares 104%

Income Statement

Label TTM Value / Value Unit Change %
General and Administrative Expense $1,615,789 USD 1282%
Operating Income (Loss) $1,615,789 USD -129959%
Net Income (Loss) Attributable to Parent $2,430,552 USD -6163%
Earnings Per Share, Basic 0 USD/shares
Earnings Per Share, Diluted 0 USD/shares -1733%

Balance Sheet

Label TTM Value / Value Unit Change %
Cash and Cash Equivalents, at Carrying Value $7,896,569 USD
Assets, Current $18,220 USD 4695%
Assets $8,313 USD 2482%
Accounts Payable, Current $60,952 USD
Liabilities, Current $999,013 USD 351%
Other Liabilities, Noncurrent $150,000 USD
Liabilities $999,013 USD 351%
Retained Earnings (Accumulated Deficit) $2,438,955 USD -999%
Stockholders' Equity Attributable to Parent $7,313,748 USD
Liabilities and Equity $8,313 USD 2482%

Popular Metrics

Label TTM Value / Value Unit Change %
Net Cash Provided by (Used in) Operating Activities $10,960 USD
Common Stock, Shares Authorized 300,000,000 shares 500%
Common Stock, Shares, Issued 17,611,292 shares 252%
Common Stock, Par or Stated Value Per Share 0 USD/shares 0%
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents $7,896,569 USD 5526%
Deferred Tax Assets, Valuation Allowance $5,119 USD 17%
Deferred Tax Assets, Gross $5,119 USD 17%
Deferred Tax Assets, Operating Loss Carryforwards $2,406 USD 8.1%
Preferred Stock, Shares Issued 0 shares
Preferred Stock, Shares Authorized 10,000,000 shares 0%
Additional Paid in Capital $9,750,942 USD
Preferred Stock, Shares Outstanding 0 shares
Preferred Stock, Par or Stated Value Per Share 0 USD/shares 0%